» Articles » PMID: 26576420

(18)F-FDG Uptake Characteristics in Differentiating Benign from Malignant Nasopharyngeal Lesions in Children

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2015 Nov 18
PMID 26576420
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The characteristics of FDG uptake in the physiologic and malignant nasopharynx were investigated in the paper which was correlated with either pathologic findings or clinical follow-up. Three patients had pathologically established nasopharyngeal malignancy. In the 3 nasopharyngeal malignancies, 2 had diffusely and expansively increased FDG uptake, and one had asymmetric uptake. Our results indicated that the difference between adenoid hypertrophy and malignancy is asymmetric or diffusely expansive (18)F-FDG uptake with or without correlating morphologic lesion on diagnostic CT in children under 10 years of age. The typical characteristics of physiologic and inflammatory (18)F-FDG uptake in nasopharynx are symmetrically trapezoid. Diffusely increased nasopharyngeal FDG uptake can be considered physiologic if SUVmax is less than 7.6 but should be carefully assessed by pharyngorhinoscopy if SUVmax is greater than 11 and there is no correlating morphologic lesion on diagnostic CT. The diffusely, expansively increased uptake, and asymmetric uptake in particular, should be considered as malignancy. Further biopsy is especially indicated in patients with retropharyngeal space and bilateral cervical lymph node abnormality but no history of malignancy.

Citing Articles

Role of 18F-FDG PET/CT in evaluating lymph node status in patients with head and neck squamous cell carcinoma.

Bianchini C, Caracciolo M, Urso L, Ciorba A, Bonsembiante A, Migliorelli A Acta Otorhinolaryngol Ital. 2023; 43(4):235-244.

PMID: 37224172 PMC: 10366561. DOI: 10.14639/0392-100X-N2370.


Solitary splenic metastasis from nasopharyngeal carcinoma: a case report and systematic review of the literature.

Genova P, Brunetti F, Bequignon E, Landi F, Lizzi V, Esposito F World J Surg Oncol. 2016; 14(1):184.

PMID: 27422630 PMC: 4947368. DOI: 10.1186/s12957-016-0941-2.

References
1.
Ayan I, Kaytan E, Ayan N . Childhood nasopharyngeal carcinoma: from biology to treatment. Lancet Oncol. 2003; 4(1):13-21. DOI: 10.1016/s1470-2045(03)00956-2. View

2.
Gordin A, Golz A, Daitzchman M, Keidar Z, Bar-Shalom R, Kuten A . Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in patients with carcinoma of the nasopharynx: diagnostic accuracy and impact on clinical management. Int J Radiat Oncol Biol Phys. 2007; 68(2):370-6. DOI: 10.1016/j.ijrobp.2006.12.028. View

3.
Radhakrishnan V, Thulkar S, Karunanithi S, Tanveer N, Bakhshi S . Nasopharyngeal carcinoma with splenic and cystic liver metastases in a pediatric patient: 18F-FDG PET-CT findings. Pediatr Radiol. 2010; 40 Suppl 1:S79-82. DOI: 10.1007/s00247-010-1844-y. View

4.
Law A, Peters L, Dutu G, Rischin D, Lau E, Drummond E . The utility of PET/CT in staging and assessment of treatment response of nasopharyngeal cancer. J Med Imaging Radiat Oncol. 2011; 55(2):199-205. DOI: 10.1111/j.1754-9485.2011.02252.x. View

5.
Cheuk D, Sabin N, Hossain M, Wozniak A, Naik M, Rodriguez-Galindo C . PET/CT for staging and follow-up of pediatric nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging. 2012; 39(7):1097-106. PMC: 3531235. DOI: 10.1007/s00259-012-2091-2. View